Finally, we assayed the CAR T cells for their ability to specifically lyse MUC1+ cancer cells by co-incubating CAR+ primary cells at various concentrations with ZR-75-1(MUC1low), T-47D (MUC1high) or HEK293T (MUC1−) target cells. The gene discussed is MUC1; the disease is cancer.